- Home
- FENC vs NBB Comparison
FENC vs NBB Comparison
Compare FENC & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$12.30
Company Overview
Basic Information| Metric | FENC | NBB |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.3M | 456.2M |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FENC | NBB |
|---|---|---|
| Price | $12.30 | $15.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 262.7K | 67.2K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $206.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $14.95 |
| 52 Week High | $13.25 | $16.62 |
Technical Indicators
Market Signals| Indicator | FENC | NBB |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 58.75 |
| Support Level | $9.74 | $15.39 |
| Resistance Level | N/A | $15.56 |
| Average True Range (ATR) | 0.57 | 0.15 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 71.73 | 84.62 |
Price Performance
Historical Comparison FENC
NBB
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund has single operating segment.